Jefferies raised the firm’s price target on Cargo Therapeutics (CRGX) to $5 from $3.70 and keeps a Hold rating on the shares. The firm believes Cargo shares could be worth near $5 when the acquisition acquisition by Concentra closes.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRGX: